Novonesis investigates gut health supplements for patients on GLP-1 weight-loss drugs
Novonesis is investigating whether gut health supplements can benefit individuals taking GLP-1 weight-loss drugs. This exploration aims to tap into a potentially lucrative emerging market connected to the popularity of these medications.
Open for the full story →